Positives and negatives of nonsteroidal anti-inflammatory drugs in bone healing: the effects of these drugs on bone repair

被引:58
|
作者
Lisowska, Barbara [1 ]
Kosson, Dariusz [2 ]
Domaracka, Karolina [3 ]
机构
[1] John Paul II Western Hosp, Dept Anesthesiol & Intens Care, Grodzisk Mazowiecki, Poland
[2] Med Univ Warsaw, Div Teaching Warsaw, Dept Anaesthesiol & Intens Care, 4 Lindley St, PL-02005 Warsaw, Poland
[3] Med Univ Warsaw, Dept Anaesthesiol & Intens Care, Warsaw, Poland
来源
关键词
bone healing; NSAIDs; negative; positive effect; ENDOTHELIAL GROWTH-FACTOR; OSTEOGENIC DIFFERENTIATION; HETEROTOPIC OSSIFICATION; FRACTURE NONUNION; INHIBITION; CYCLOOXYGENASE-2; INDOMETHACIN; INCREASES; PROPHYLAXIS; EXPRESSION;
D O I
10.2147/DDDT.S164565
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Tissue damage following injury triggers the processes of coagulation, inflammation and healing. In tissues surrounding the bone, the result of the healing process is a scar, while bone tissue has a unique ability to achieve shape, strength and pre-injury function. Bone healing is a process of regeneration rather than classic recovery. The result of this process is the formation of new, healthy bone tissue instead of a scar. Many factors can inhibit or impair the bone healing process, and their influence is critical during the stages of inflammation and angiogenesis and finally on the clinical outcome. Nonsteroidal anti-inflammatory drugs (NSAIDs) play an essential role associated with their analgesic potency and anti-inflammatory effects. NSAIDs are also the most often used drugs in patients who require pain control and inflammation reduction due to musculoskeletal diseases or injures. Although their analgesic effect is well documented, NSAIDs also interfere with bone healing; therefore, the relative benefits and disadvantages connected with their administration should be taken into consideration. Despite the negative effect, NSAIDs have beneficial properties, but their clinical benefits in relation to dose and time of use are still unclear. Therefore, in this review, we focus on bone healing with relation to the impact of NSAIDs.
引用
收藏
页码:1809 / 1814
页数:6
相关论文
共 50 条
  • [41] NEPHROTOXICITY OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
    KHOKHAR, N
    AMERICAN FAMILY PHYSICIAN, 1984, 30 (01) : 123 - 128
  • [42] NEPHROTOXICITY OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
    HAGLER, L
    AMERICAN FAMILY PHYSICIAN, 1984, 30 (05) : 27 - 29
  • [43] Nonsteroidal anti-inflammatory drugs and pharyngitis
    Mazzone, Stuart B.
    Kulasekaran, Anuradha
    Shea, Tim
    Adegoke, Oluwajoba
    IMMUNITY INFLAMMATION AND DISEASE, 2022, 10 (12)
  • [44] A review of nonsteroidal anti-inflammatory drugs
    Schellack, Natalie
    Schellack, Gustav
    Fourie, Johani
    SA PHARMACEUTICAL JOURNAL, 2015, 82 (03) : 8 - 18
  • [45] The nonsteroidal anti-inflammatory drugs controversy
    Yeomans, ND
    Garas, G
    Hawkey, CJ
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2000, 29 (04) : 791 - +
  • [46] PHOTOSENSITIVITY TO NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
    FIGUEINEDO, A
    TEIXEIRA, E
    POIARESBAPTISTA, A
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1989, 28 (02) : 139 - 140
  • [47] Nonsteroidal Anti-inflammatory Drugs in Ophthalmology
    Kim, Stephen J.
    Flach, Allan J.
    Jampol, Lee M.
    SURVEY OF OPHTHALMOLOGY, 2010, 55 (02) : 108 - 133
  • [48] Pharmacogenetics of nonsteroidal anti-inflammatory drugs
    J E Wyatt
    W L Pettit
    S Harirforoosh
    The Pharmacogenomics Journal, 2012, 12 : 462 - 467
  • [49] Nonsteroidal anti-inflammatory drugs in the cat
    Jones, Ronald S.
    VETERINARY ANAESTHESIA AND ANALGESIA, 2007, 34 (04) : 225 - 227
  • [50] Nonsteroidal anti-inflammatory drugs for dysmenorrhoea
    Marjoribanks, Jane
    Proctor, Michelle
    Farquhar, Cindy
    Derks, Roos S.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (01):